Comparing the Effects of Extracorporeal Shockwave Therapy and Splinting in the Treatment of Trigger Finger
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMahidol University
About this trial
The goal of this study is to compare the effects of extracorporeal shockwave therapy and splinting in the treatment of trigger finger.
Participants will:
Be randomized into two groups (shockwave group and splint group). Visit the clinic once a week for four weeks for therapy. Keep a diary of their symptoms, which will be reviewed at six weeks.
Eligibility criteria
Qualifiers
Patients age ≥ 18 years
Grade I-III trigger finger patients (patients who has the presence of tenderness over the A1 pulley or painful locking or triggering as they fixed and extended the finger)
Patients who consented to participation in the study
Disqualifiers
Trigger thumb
The patients who had received previous treatment (steroid injection, ESWT or surgical release)
Patients with local infections, malignancies, severe coagulopathy and pregnancy
Trial design
Treatments tested in this trial
- Shockwave
- Splint
Treatment groups
24 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov